Drug archive
Hydroxyurea (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antineoplastic
- Antianemic
Description
Hydroxyurea (hye-DROX-ee-yoo-REE-ah)belongs to the group of medicines called antimetabolites. It is used to treat some kinds of cancer and to prevent painful episodes associated with sickle cell anemia.
Hydroxyurea seems to interfere with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by hydroxyurea, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects may not be serious but may cause concern. Some effects may not occur for months or years after the medicine is used.
When used in sickle cell anemia, hydroxyurea appears to increase the flexibility of sickled cells.
Before you begin treatment with hydroxyurea, you and your doctor should talk about the good this medicine will do as well as the risks of using it.
Hydroxyurea is available only with your doctor's prescription, in the following dosage form:
- Capsules (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Hydrea
- Droxia
In Canada -
- Hydrea